Effect of 12 weeks rehabilitation (aspect of neuromuscular physical therapy) in middle-aged patients in post-atroscopic period

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004087-30-EE

Enrollment

Registered

2011-08-22

Start date

2011-08-25

Completion date

Unknown

Last updated

2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cartilage Lesion of the Knee Joint MedDRA version: 14.0 Level: LLT Classification code 10023476 Term: Knee osteoarthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders

Interventions

Trade Name: SonoVue Pharmaceutical Form: Dispersion for injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Arthroscopy age 34-60 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Contraindications to use of SonoVue

Design outcomes

Primary

Measure	Time frame
Main Objective: Assess the outcome of an exercise therapy (ExT) programme with longer duration (12 weeks) and higher intensity, focusing on the neuromuscular aspect in ExT.;Secondary Objective: * post-arthroscopy quality of life of the patient depends on the location and severity of cartilage damage *twelve-week neuromus¬cular ExT (nExT) has long term (12-month) effect on the patient’s quality of life. ;Primary end point(s): 1) knee-specific standardised questionnaire KOOS 2) range of motion of the hip and knee, 3) several performance tests of the lower limb ;Timepoint(s) of evaluation of this end point: The following parameters were measured in baseline and after the exercise therapy course 3 month after: 1) knee-specific standardised questionnaire KOOS 2) range of motion of the hip and knee, 3) several performance tests of the lower limb	—

Measure

Time frame

Main Objective: Assess the outcome of an exercise therapy (ExT) programme with longer duration (12 weeks) and higher intensity, focusing on the neuromuscular aspect in ExT.;Secondary Objective: * post-arthroscopy quality of life of the patient depends on the location and severity of cartilage damage *twelve-week neuromus¬cular ExT (nExT) has long term (12-month) effect on the patient’s quality of life. ;Primary end point(s): 1) knee-specific standardised questionnaire KOOS 2) range of motion of the hip and knee, 3) several performance tests of the lower limb ;Timepoint(s) of evaluation of this end point: The following parameters were measured in baseline and after the exercise therapy course 3 month after: 1) knee-specific standardised questionnaire KOOS 2) range of motion of the hip and knee, 3) several performance tests of the lower limb

—

Countries

Estonia

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026